Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study

scientific article

Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/00365520150218057
P698PubMed publication ID11218239

P2093author name stringMortensen PB
Szkudlarek J
Jeppesen PB
Høy CE
P2860cites workEffect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resectionQ35353776
Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.Q38530478
Human body composition: advances in models and methodsQ40912261
P433issue1
P921main subjectfatty acidQ61476
placeboQ269829
P304page(s)48-54
P577publication date2001-01-01
P1433published inScandinavian Journal of GastroenterologyQ7429960
P1476titleEffect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study
P478volume36

Reverse relations

cites work (P2860)
Q43268424Abuse of growth hormone increases the risk of persistent de Quervain tenosynovitis
Q34726758Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges
Q35201118Clinical evidence for enteral nutritional support with glutamine: a systematic review
Q36308924Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients
Q34767824Enhancing bowel adaptation in short bowel syndrome
Q33369915Example of safety measures for antineoplastic agents immediately after market launch--a case of TS-1 capsule all example use result investigation that executes safety monitoring--
Q35595149Experimental approaches: dietary and hormone therapy.
Q57611559Growth Hormone Favorably Affects Bone Turnover and Bone Mineral Density in Patients With Short Bowel Syndrome Undergoing Intestinal Rehabilitation
Q38197594Growth hormone for intestinal adaptation in patients with short bowel syndrome: systematic review and meta-analysis of randomized controlled trials
Q33867801Intestinal mucosal adaptation
Q88475696Management of Pediatric Intestinal Failure
Q37898793Management of pediatric intestinal failure
Q42914110Mechanical Extension Implants for Short-Bowel Syndrome
Q35190608New and emerging therapies for short bowel syndrome in children
Q37016607Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches
Q37811028Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children
Q39302506The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases
Q24793103The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review
Q36451413The use of hormonal growth factors in the treatment of patients with short-bowel syndrome.
Q38156844Where are we at with short bowel syndrome and small bowel transplant

Search more.